Simvastatin Tablets
Reason Presence of foreign substance: metallic razor blade was found in one bottle.
17,898 recalls, newest first
Reason Presence of foreign substance: metallic razor blade was found in one bottle.
Reason Failed Content Uniformity Specifications
Reason Lack of Assurance of Sterility: Leakage of the peritoneal dialysis (PD) solution bag.
Reason Presence of Particulate Matter; white particulate matter identified as mold was found in one bag
Reason Failed Stability Specifications:stability failure at 12 months, long term RT conditions.
Reason Failed Stability Specifications:stability failure at 12 months, long term RT conditions.
Reason Cross Contamination With Other Products: metronidazole powder was found in one bottle of Divalproex Sodium.
Reason Subpotent Drug
Reason Subpotent Drug
Reason Presence of particulate matter
Reason CGMP Deviations: Inadvertent release of a drug product with unapproved active ingredient manufacturer.
Reason Presence of Particulate Matter: identified as polyethylene, which is consistent with the material used to manufacture the contain cap
Reason Failed Stability Specifications
Reason GMP Deviations: manufacturing of API material did not meet GMP and quality requirements.
Reason GMP Deviations: manufacturing of API material did not meet GMP and quality requirements.
Reason GMP Deviations: manufacturing of API material did not meet GMP and quality requirements.
Reason GMP Deviations: manufacturing of API material did not meet GMP and quality requirements.
Reason GMP Deviations: manufacturing of API material did not meet GMP and quality requirements.
Reason Failed Impurities/Degradation Specifications: High out of specification test result for the Moexipril Diketopiperazine impurity was obtained during routine stability testing.
Reason Failed Stability Specifications: Product stability testing results did not meet specifications for iron content.
Reason Microbial Contamination of Non-Sterile Products: potentially contamination with the bacteria Burkholderia cepacia
Reason Presence of Foreign Substance: Reports have been received of damaged StripPax packets containing silica gel desiccant potentially allowing the silica gel granules to make contact with Auryxia tablets in the bottle.
Reason Marketed without an approved NDA/ANDA: FDA analysis found the product to contain undeclared sibutramine.
Reason Defective Container: products showed leakage (bubbles, foaming) of propellant and product from the container valve cup area.
Reason Defective Container: products showed leakage (bubbles, foaming) of propellant and product from the container valve cup area.